Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART

Oral Diseases

Volumn 18, Issue 8, 2012, Pages 793-801

  Nittayananta, W ^a   Mitarnun, W ^a   Talungchit, S ^b   Sriplung, H ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Cytokeratin; HAART; HIV; Oral health; Oral lesion; Risk factor

Indexed keywords

CYTOKERATIN 1; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 16; INVOLUCRIN;

ADULT; ARTICLE; CHEEK MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFERENTIATION; EPITHELIUM CELL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH; MOUTH MUCOSA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PUNCH BIOPSY;

3,3'-DIAMINOBENZIDINE; ADULT; ALCOHOL DRINKING; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY, NEEDLE; CD4 LYMPHOCYTE COUNT; CHROMOGENIC COMPOUNDS; CROSS-SECTIONAL STUDIES; EPITHELIAL CELLS; FEMALE; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KERATIN-1; KERATIN-13; KERATIN-14; KERATIN-16; KERATINS; MALE; MIDDLE AGED; MOUTH MUCOSA; PROTEIN PRECURSORS; SMOKING; VIRAL LOAD; YOUNG ADULT;

EID: 84866864081     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01947.x     Document Type: Article

References (39)

1. Adler DH (2010). The impact of HAART on HPV-related cervical disease. Curr HIV Res8: 493-497.
2. Amornthatree K, Sriplung H, Mitarnun W, Nittayananta W (2012). The impacts of long-term use of antiretroviral therapy on the prevalence of oral human papilloma virus type 16. J Oral Pathol Med41: 309-314.
3. Baker H, Patel V, Molinolo AA et al (2005). Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol41: 183-199.
4. Bedimo R (2008). Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Curr HIV/AIDS Rep5: 140-149.
5. Challacombe SJ, Sweet SP (2002). Oral mucosal immunity and HIV infection: current status. Oral Dis8(Suppl 2): 55-62.
6. Clifford GM, Polesel J, Rickenbach M et al (2005). Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst97: 425-432.
7. Dale BA, Fredericks LP (2005). Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol7: 119-133.
8. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus (1993). Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med22: 289-291.
9. Fillies T, Werkmeister R, Packeisen J et al (2006). Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer6: 10.
10. Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H (2007). Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep18: 639-643.
11. Gillison ML (2009). Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol21: 439-444.
12. Gires O, Mack B, Rauch J, Matthias C (2006). CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck. Biochem Biophys Res Commun343: 252-259.
13. Glick M, Muzyka BC, Lurie D, Salkin LM (1994). Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol77: 344-349.
14. Hammer SM, Eron JJ Jr, Reiss P et al (2008). Antiretroviral treatment of adult HIV infection: 2008 recommendations of the international AIDS society USA panel. JAMA300: 555-570.
15. Herrero R, Castellsague X, Pawlita M et al (2003). Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst95: 1772-1783.
16. Hunter KD, Parkinson EK, Harrison PR (2005). Profiling early head and neck cancer. Nat Rev Cancer5: 127-135.
17. Imai FL, Uzawa K, Nimura Y et al (2005). Chromosome 1 open reading frame 10 (C1orf10) gene is frequently down-regulated and inhibits cell proliferation in oral squamous cell carcinoma. Int J Biochem Cell Biol37: 1641-1655.
18. Laskaris G, Hadjivassiliou M, Stratigos J (1992). Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med21: 120-123.
19. Matthias C, Mack B, Berghaus A, Gires O (2008). Keratin 8 expression in head and neck epithelia. BMC Cancer8: 267.
20. Moll R, Divo M, Langbein L (2008). The human keratins: biology and pathology. Histochem Cell Biol129: 705-733.
21. Mork J, Lie AK, Glattre E et al (2001). Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med344: 1125-1131.
22. Nittayananta W, Chungpanich S (1997). Oral lesions in a group of Thai people with AIDS. Oral Dis3(Suppl 1): S41-45.
23. Ohkura S, Kondoh N, Hada A et al (2005). Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol41: 607-613.
24. Olivero OA (2007). Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen48: 215-223.
25. Patel V, Hood BL, Molinolo AA et al (2008). Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res14: 1002-1014.
26. Presland RB, Dale BA (2000). Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med11: 383-408.
27. Sakamoto K, Aragaki T, Morita K et al (2011). Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis. Histopathology58: 531-542.
28. Schaaij-Visser TB, Graveland AP, Gauci S et al (2009). Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res15: 7666-7675.
29. Schaaij-Visser TB, Bremmer JF, Braakhuis BJ et al (2010). Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Oral Oncol46: 123-127.
30. Seaberg EC, Wiley D, Martínez-Maza O (2010). Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer116: 5507-5516.
31. Shiboski CH, Patton LL, Webster-Cyriaque JY et al (2009). The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints. J Oral Pathol Med38: 481-488.
32. Silverberg MJ, Chao C, Leyden WA (2009). HIV infection and the risk of cancers with and without a known infectious cause. AIDS23: 2337-2345.
33. Simard EP, Pfeiffer RM, Engels EA (2010). Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med170: 1337-1345.
34. Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J (2008). Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. J Cancer Res Clin Oncol134: 515-521.
35. Wei KJ, Zhang L, Yang X et al (2009). Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo. Oral Dis15: 111-117.
36. Weiss RA, Eichner R, Sun TT (1984). Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol98: 1397-1406.
37. White JS, Weissfeld JL, Ragin C et al (2007). The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol43: 701-712.
38. Yanagawa T, Yoshida H, Yamagata K et al (2007). Loss of cytokeratin expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence. J Exp Clin Cancer Res26: 215-220.
39. Zhong LP, Chen WT, Zhang CP, Zhang ZY (2007). Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod104: 377-384.